Apellis Pharmaceuticals Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $73.80 on 01/09/24, while the lowest value for the same period was recorded at $26.28 on 10/10/24.
52-week price history of APLS Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Apellis Pharmaceuticals Inc’s current trading price is -62.60% away from its 52-week high, while its distance from the 52-week low is 5.02%. The stock’s price range during this period has spanned from $26.28 to $73.80. In the Healthcare sector, the Apellis Pharmaceuticals Inc’s shares surpassed a trading volume of approximately 3.47 million for the day, which was noticeably higher compared to the average daily volume of 9.2.05 million over the past three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Market Capitalization and Financial Performance: An In-Depth Look
Apellis Pharmaceuticals Inc (APLS) has experienced a quarterly decline of -26.18% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.36B and boasts a workforce of 706 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 36.22, with a change in price of -13.15. Similarly, Apellis Pharmaceuticals Inc recorded 1,840,568 in trading volume during the last 100 days, posting a change of -32.27%.
Examining APLS’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for APLS stands at 1.80. Similarly, the long-term debt-to-equity ratio is also 1.77.
APLS Stock Stochastic Average
Today, Apellis Pharmaceuticals Inc’s raw stochastic average for the past 50 days stands at 8.43%, indicating a decline from the raw stochastic average of the last 20 days, which was 27.68%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 21.11% and 19.93% respectively.
APLS Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The metric has seen a significant loss of -53.89% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -43.35%. Over the past 30 days, the price of APLS has leaped by -15.65%. And in the last five days, it has fallen by -1.25%.
